Aeris Biotechnologies
About this raise
Aeris Biotechnologies is raising funds through Reg A+ crowdfunding with Dalmore Group as the Broker-Dealer. The company is bringing an innovative and green approach to the treatment of asthma. The business has developed a first-of-its-kind, in-home, and affordable treatment kit to control the dust mites and associated allergens that cause asthma. The technology of Aeris Biotechnologies is green, scalable, and patent-protected. Aaron Michael Gunn and Dr. David Richard Harper founded Aeris Biotechnologies in 2021. The current crowdfunding campaign has a maximum target of $15,000,000. The campaign proceeds will be used for business development, marketing, research and development, product development, and working capital.
Investment Overview
Invested : $95,200
Deal Terms
Total Commitments
- Platform
- Dalmore Group
- Start Date
- 07/26/2022
- Close Date
- 06/08/2023
$500
$15,000,000
$500
Equity - Common
Pre-Seed
RegA+
$1.00
$28,350,000
Company & Team
Company
- Year Founded
- 2021
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 06/08/2023 | Dalmore Group | $28,350,000 | $95,200 | Equity - Common | Funded | RegA+ |